Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-04-29
1982-09-07
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3127
Patent
active
043484077
ABSTRACT:
It has been found that fungal diseases can be effectively treated systemically by oral administration of tolciclate or tolnaftate. The drugs will generally be administered in divided daily doses in the form of tablets, capsules, syrups or suspensions.
REFERENCES:
patent: 3855263 (1974-12-01), Melloni et al.
The Merck Index, 9th Ed., Merck & Co. Inc., Rathway, N.J., 1976, p. 1224 (WO 9216).
Noguchi et al., Antimicrobial Agents and Chemotherapy-1962 (May, 1963), pp. 259-267.
Imondi Anthony R.
Shemano Irving
Adria Laboratories Inc.
Goldberg Jerome D.
Staves Marion C.
LandOfFree
Orally active tolciclate and tolnaftate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orally active tolciclate and tolnaftate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally active tolciclate and tolnaftate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1342258